CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar.
暂无分享,去创建一个
S. Schwartz | M. Resnick | T. P. Pretlow | S. Amini | H. Kung | T. Pretlow | P. Gumerlock | C. Miller | R. D. White | R. de Vere White | M. Nagabhushan | J. M. Giaconia | N. Edgehouse | Stuart Schwartz | T P Pretlow | T G Pretlow | Joseph M. Giaconia